FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Test and Report Leachable Nitrosamines: FDA

[ Price : $8.95]

An FDA guidance asks manufacturers and applicants of drug products packed in infusion bags to collect and report data on nitrosami...

NeuroOnes Trigeminal Nerve Ablation Cleared

[ Price : $8.95]

FDA clears a NeuroOne Medical Technologies 510(k) to market its OneRF Trigeminal Nerve Ablation System for use in procedures to cr...

Multiple Les Encres Violations

[ Price : $8.95]

FDA warns Lenoir City, TN-based Les Encres LLC about QS and MDR violations in its illegal work as a specification developer for ad...

Alcohol Use Disorder Drug Gets Fast Track

[ Price : $8.95]

FDA grants Altimmune a fast track designation for pemvidutide and its use for treating alcohol use disorder.

Cancer Radiopharm. Dosage Guide

[ Price : $8.95]

FDA posts a new draft guidance entitled Oncology Therapeutic Radiopharmaceuticals (RPTs): Dosage Optimization During Clinical Deve...

Stealth Refiles NDA for Barth Syndrome Drug

[ Price : $8.95]

Stealth BioTherapeutics resubmits its NDA for elamipretide for treating Barth syndrome.

Court Orders FDA to Reconsider Vanda sNDA

[ Price : $8.95]

An appeals court rules that FDA improperly rejected Vanda Pharmaceuticals request for a hearing on its supplemental NDA for sleep ...

Advisory Panel Conflicts of Interest Low: Study

[ Price : $8.95]

A new study in JAMA finds that conflicts of interest among federal vaccine advisors had fallen to historic lows well before HHS se...

Tandem Recalls Insulin Pumps Due to Alarm Error

[ Price : $8.95]

Tandem Diabetes Care recalls (Class 1 device correction) certain t:slim X2 insulin pumps to address a potential speaker-related is...

Workshop on Patient Experience Data in Drug Development

[ Price : $8.95]

FDA announces a two-day virtual public workshop to address methodological challenges in using patient experience data in drug deve...